Increasing AR by HIF-2α inhibitor (PT-2385) overcomes the side-effects of sorafenib by suppressing hepatocellular carcinoma invasion via alteration of pSTAT3, pAKT and pERK signals.
about
Increasing AR by HIF-2α inhibitor (PT-2385) overcomes the side-effects of sorafenib by suppressing hepatocellular carcinoma invasion via alteration of pSTAT3, pAKT and pERK signals.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Increasing AR by HIF-2α inhibi ...... pSTAT3, pAKT and pERK signals.
@en
Increasing AR by HIF-2α inhibi ...... pSTAT3, pAKT and pERK signals.
@nl
type
label
Increasing AR by HIF-2α inhibi ...... pSTAT3, pAKT and pERK signals.
@en
Increasing AR by HIF-2α inhibi ...... pSTAT3, pAKT and pERK signals.
@nl
prefLabel
Increasing AR by HIF-2α inhibi ...... pSTAT3, pAKT and pERK signals.
@en
Increasing AR by HIF-2α inhibi ...... pSTAT3, pAKT and pERK signals.
@nl
P2093
P2860
P356
P1476
Increasing AR by HIF-2α inhibi ...... pSTAT3, pAKT and pERK signals.
@en
P2093
Jiang Chen
Longbo Zheng
Minyue Tang
Ren-An Jin
Xiao Liang
Xiujun Cai
P2860
P2888
P356
10.1038/CDDIS.2017.411
P577
2017-10-12T00:00:00Z
P6179
1092186462